AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 1-25/56
LOW-MOLECULAR-WEIGHT HEPARIN AS AN ADJUNCT TO THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE FATIMA STUDY
Authors: CHAMULEAU SAJ DEWINTER RJ LEVI M ADAMS R BULLER HR PRINS MH LIE KI PETERS RJG
Citation: Saj. Chamuleau et al., LOW-MOLECULAR-WEIGHT HEPARIN AS AN ADJUNCT TO THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE FATIMA STUDY, HEART, 80(1), 1998, pp. 35-39
REPLACING INPATIENT CARE BY OUTPATIENT CARE IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - AN ECONOMIC-EVALUATION
Authors: VANDENBELT AGM BOSSUYT PMM PRINS MH GALLUS AS BULLER HR
Citation: Agm. Vandenbelt et al., REPLACING INPATIENT CARE BY OUTPATIENT CARE IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - AN ECONOMIC-EVALUATION, Thrombosis and haemostasis, 79(2), 1998, pp. 259-263
EVALUATION OF DIAGNOSTIC TECHNOLOGIES - APPLICABILITY OF CURRENT STRATEGIES
Authors: LIJMER JG MOL BW BONSEL GJ PRINS MH BOSSUYT PMM
Citation: Jg. Lijmer et al., EVALUATION OF DIAGNOSTIC TECHNOLOGIES - APPLICABILITY OF CURRENT STRATEGIES, Medical decision making, 18(4), 1998, pp. 471-471
LIPOPROTEIN(A) CONCENTRATIONS IN PATIENTS WITH A HISTORY OF SEVERE PREECLAMPSIA - A CASE-CONTROL STUDY
Authors: VANPAMPUS MG KOOPMAN MMW WOLF H BULLER HR PRINS MH
Citation: Mg. Vanpampus et al., LIPOPROTEIN(A) CONCENTRATIONS IN PATIENTS WITH A HISTORY OF SEVERE PREECLAMPSIA - A CASE-CONTROL STUDY, Clinical chemistry, 44, 1998, pp. 360-360
UNDIAGNOSED MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE, RISK INDICATORS, AND DIAGNOSIS
Authors: HETTIARACHCHI RJK LOK J PRINS MH BULLER HR PRANDONI P
Citation: Rjk. Hettiarachchi et al., UNDIAGNOSED MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE, RISK INDICATORS, AND DIAGNOSIS, Cancer, 83(1), 1998, pp. 180-185
PREVALENCE OF HEREDITARY HEMOCHROMATOSIS IN PREMATURE ATHEROSCLEROTICVASCULAR-DISEASE
Authors: FRANCO RF ZAGO MA TRIP MD TENCATE H VANDENENDE A PRINS MH KASTELEIN JJP REITSMA PH
Citation: Rf. Franco et al., PREVALENCE OF HEREDITARY HEMOCHROMATOSIS IN PREMATURE ATHEROSCLEROTICVASCULAR-DISEASE, British Journal of Haematology, 102(5), 1998, pp. 1172-1175
FACTOR-11 20210-G-]A POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK FOR ARTERIAL THROMBOTIC DISEASE AND AUGMENTED THROMBIN GENERATION
Authors: FRANCO RF TRIP MD TENCATE H VANDENENDE A PRINS MH KASTELEIN JJP REITSMA PH
Citation: Rf. Franco et al., FACTOR-11 20210-G-]A POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK FOR ARTERIAL THROMBOTIC DISEASE AND AUGMENTED THROMBIN GENERATION, British Journal of Haematology, 102(1), 1998, pp. 147-147
PREVALENCE OF HLA-H MUTATIONS IN PATIENTS WITH PREMATURE ARTERIAL-DISEASE
Authors: FRANCO RF TRIP MD TENCATE H PRINS MH KASTELEIN JJP ZAGO MA REITSMA PH
Citation: Rf. Franco et al., PREVALENCE OF HLA-H MUTATIONS IN PATIENTS WITH PREMATURE ARTERIAL-DISEASE, British Journal of Haematology, 102(1), 1998, pp. 257-257
THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN FAMILY MEMBERS OF PATIENTSWITH FACTOR-V-LEIDEN MUTATION AND VENOUS THROMBOSIS
Authors: MIDDELDORP S HENKENS CMA KOOPMAN MMW VANPAMPUS ECM HAMULYAK K VANDERMEER J PRINS MH BULLER HR
Citation: S. Middeldorp et al., THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN FAMILY MEMBERS OF PATIENTSWITH FACTOR-V-LEIDEN MUTATION AND VENOUS THROMBOSIS, Annals of internal medicine, 128(1), 1998, pp. 15
THE PREVALENCE OF THE 20210-G-GREATER-THAN-A MUTATION IN THE 3'-UNTRANSLATED REGION OF THE PROTHROMBIN GENE IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE
Authors: FRANCO RF TRIP MD TENCATE H PRINS MH KASTELEIN JJP REITSMA PH
Citation: Rf. Franco et al., THE PREVALENCE OF THE 20210-G-GREATER-THAN-A MUTATION IN THE 3'-UNTRANSLATED REGION OF THE PROTHROMBIN GENE IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 1997, pp. 12-12
ANTITHROMBOTIC DRUGS AFTER REVASCULARIZATION PROCEDURE FOR PERIPHERALARTERIAL-DISEASE
Authors: GIROLAMI B BERNARDI E PRANDONI P SIMIONI P GIROLAMI A PRINS MH
Citation: B. Girolami et al., ANTITHROMBOTIC DRUGS AFTER REVASCULARIZATION PROCEDURE FOR PERIPHERALARTERIAL-DISEASE, Thrombosis and haemostasis, 1997, pp. 520-520
ANTITHROMBOTIC DRUGS FOR INTERMITTENT CLAUDICATION
Authors: GIROLAMI B BERNARDI E STEFANI PM PRANDONI P GIROLAMI A PRINS MH
Citation: B. Girolami et al., ANTITHROMBOTIC DRUGS FOR INTERMITTENT CLAUDICATION, Thrombosis and haemostasis, 1997, pp. 522-522
BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE
Authors: GRAAFSMA YP PRINS MH LENSING AWA HUISMAR MV BULLER HR
Citation: Yp. Graafsma et al., BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE, Thrombosis and haemostasis, 1997, pp. 1181-1181
OCCULT MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE AND RISK INDICATORS
Authors: HETTIARACHCHI RJK PRINS MH BULLER HR PRANDONI P TENCATE JW
Citation: Rjk. Hettiarachchi et al., OCCULT MALIGNANCY IN PATIENTS WITH DEEP-VEIN THROMBOSIS - INCIDENCE AND RISK INDICATORS, Thrombosis and haemostasis, 1997, pp. 1563-1563
TACT-STUDY - A MULTICENTER PROSPECTIVE COHORT STUDY TO ASSESS THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN ASYMPTOMATIC CARRIERS OF A MARKER OF THROMBOPHILIA - PRELIMINARY-RESULTS
Authors: SANSON BJ SIMIONI P MOLA M FRIEDERICH PW TORMENE D REJTO L GAVASSO S MANNUCCI PM SONIA L VANTWILLERT G PRANDONI P TENCATE JW GIROLAMI A BULLER H HUISMAN MV PRINS MH
Citation: Bj. Sanson et al., TACT-STUDY - A MULTICENTER PROSPECTIVE COHORT STUDY TO ASSESS THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN ASYMPTOMATIC CARRIERS OF A MARKER OF THROMBOPHILIA - PRELIMINARY-RESULTS, Thrombosis and haemostasis, 1997, pp. 2349-2349
DOES THE RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE FAMILY MEMBERS OF PATIENTS WITH VTE AND THE FV-Q(506) MUTATION JUSTIFY FAMILYSCREENING
Authors: MIDDELDORP S HENKENS CMA KOOPMAN MMW VANPAMPUS ECM HAMULYAK K VANDERMEER J PRINS MH BULLER HR
Citation: S. Middeldorp et al., DOES THE RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE FAMILY MEMBERS OF PATIENTS WITH VTE AND THE FV-Q(506) MUTATION JUSTIFY FAMILYSCREENING, Thrombosis and haemostasis, 1997, pp. 2370-2370
THE INCIDENCE OF RECURRENT THROMBOEMBOLIC AND BLEEDING COMPLICATIONS AMONG PATIENTS WITH VENOUS THROMBOEMBOLISM IN RELATION TO MALIGNANCY AND ACHIEVED INR
Authors: HUTTEN BA PRINS MH TIJSSEN JGP BULLER HR
Citation: Ba. Hutten et al., THE INCIDENCE OF RECURRENT THROMBOEMBOLIC AND BLEEDING COMPLICATIONS AMONG PATIENTS WITH VENOUS THROMBOEMBOLISM IN RELATION TO MALIGNANCY AND ACHIEVED INR, Thrombosis and haemostasis, 1997, pp. 2398-2398
HEMOSTATIC RISK-FACTORS AND THE RISK OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Authors: KUIJER PMM GALLUS AS CHESTERMAN CN PRINS MH BULLER HR
Citation: Pmm. Kuijer et al., HEMOSTATIC RISK-FACTORS AND THE RISK OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 2920-2920
THE INCIDENCE OF RISK-RELATED VENOUS THROMBOEMBOLISM IN SUBJECTS WITHHEREDITARY THROMBOPHILIA
Authors: SIMIONI P SANSON BJ PRANDONI P GIROLAMI B FRIEDERICH PW TORMENE D HUISMAN MV SARDELLA C BULLER HR TENCATE JW GIROLAMI A PRINS MH
Citation: P. Simioni et al., THE INCIDENCE OF RISK-RELATED VENOUS THROMBOEMBOLISM IN SUBJECTS WITHHEREDITARY THROMBOPHILIA, Thrombosis and haemostasis, 1997, pp. 2921-2921
GENETIC SUSCEPTIBILITY TO PREECLAMPSIA - INVOLVEMENT OF FACTOR-V-LEIDEN MUTATION
Authors: MEINARDI JR MIDDELDORP S KOOPMAN MMW VANPAMPUS ECM HAMULYAK K PRINS MH BULLER HR VANDERMEER J
Citation: Jr. Meinardi et al., GENETIC SUSCEPTIBILITY TO PREECLAMPSIA - INVOLVEMENT OF FACTOR-V-LEIDEN MUTATION, Thrombosis and haemostasis, 1997, pp. 3101-3101
BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE
Authors: GRAAFSMA YP PRINS MH LENSING AWA DEHAAN RJ HUISMAN MV BULLER HR
Citation: Yp. Graafsma et al., BLEEDING CLASSIFICATION IN CLINICAL-TRIALS - OBSERVER VARIABILITY ANDCLINICAL RELEVANCE, Thrombosis and haemostasis, 78(4), 1997, pp. 1189-1192
ANTITHROMBIN ACTS AS A NEGATIVE ACUTE-PHASE PROTEIN AS ESTABLISHED WITH STUDIES ON HEPG2 CELLS AND IN BABOONS
Authors: NIESSEN RWLM LAMPING RJ JANSEN PM PRINS MH PETERS M TAYLOR FB DEVIJLDER JJM TENCATE JW HACK CE STURK A
Citation: Rwlm. Niessen et al., ANTITHROMBIN ACTS AS A NEGATIVE ACUTE-PHASE PROTEIN AS ESTABLISHED WITH STUDIES ON HEPG2 CELLS AND IN BABOONS, Thrombosis and haemostasis, 78(3), 1997, pp. 1088-1092
NEWLY-DIAGNOSED MALIGNANCY IN PATIENTS WITH VENOUS THROMBOEMBOLISM - SEARCH OR WAIT AND SEE
Authors: PRINS MH HETTIARACHCHI RJK LENSING AWA HIRSH J
Citation: Mh. Prins et al., NEWLY-DIAGNOSED MALIGNANCY IN PATIENTS WITH VENOUS THROMBOEMBOLISM - SEARCH OR WAIT AND SEE, Thrombosis and haemostasis, 78(1), 1997, pp. 121-125
LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM
Authors: TENCATE JW BULLER HR GENT M HIRSH J PRINS MH BAILDON R LENSING AWA ANDERSON DR VANBEEK EJR FIESINGER JN TIJSSEN JGP VANBARNEVELD A EIMERS LT GRAAFSMA YP HETTIARACHCHI R HUTTEN B REDEKOP K HALEY S LIBERALE L FINCH T WHITTAKER S WILKINSON L PRANDONI P VILLALTA S GIROLAMI B BAGATELLA P ROSSI L GIROLAMI A PIOVELLA F BARONE M BELTRAMETTI C SERAFINI S SIRAGUSA S ASCARI E KOVACS MJ MORROW B KOVACS J KUIJER PMM KOOPMAN MMW JAGT H WEITZ J KEARON C BIAGIONI L HAAS S LOSSNER F SPENGEL FA BERGER M DEMERS C POULIN J VANDERMEER J QUE GTH SMID WM ROBINSON KS BOYLE E LECLERC JR STJACQUES B FINKENBINE S GALLUS AS COHLAN D RICH C BRANDJES DPM HOEFNAGEL CA DERIJK M TURKSTRA F DESJARDINS L COTEDESJARDINS J COUTURE L RUEL M VILLENUEVE J GEERTS WH JAY RM CODE EKI TURPIE AGG JOHNSON J NGUYEN P CUSSON JR ROY S WELLS PS BORMANIS J GOUDIE D CRUICKSHANK M VONLEWINSKI M MONREAL M SAHUQUILLO JC LAFOZ E SIMONNEAU G PARENT F JAGOT J DOUKETIS JD KINNON K GINSBERG JS BRILLEDWARDS P DONOVAN D OCKELFORD PA KASSIS J BORNAIS S PLANCHON B ELKOURI D PISTORIUS MA ESCRIBANO M GARRIDO G CHESTERMAN CN CHONG BH PRITCHARD S CADE JF BYNON T STANFORD J BRIEN WM PALMER B FAIVRE R PETITEAU B MANUCCI PM MOIA M BUCCIARELLI P
Citation: Jw. Tencate et al., LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM, The New England journal of medicine, 337(10), 1997, pp. 657-662
THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AN ARG(506)-]GLN MUTATION IN THE GENE FOR FACTOR-V (FACTOR-V LEIDEN)
Authors: SIMIONI P PRANDONI P LENSING AWA SCUDELLER A SARDELLA C PRINS MH VILLALTA S DAZZI F GIROLAMI A
Citation: P. Simioni et al., THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AN ARG(506)-]GLN MUTATION IN THE GENE FOR FACTOR-V (FACTOR-V LEIDEN), The New England journal of medicine, 336(6), 1997, pp. 399-403
Risultati: 1-25 | 26-50 | 51-56